trajenta Duo

Introduction to trajenta Duo

Trajenta Duo is a combination medication available in tablet form, primarily used for managing type 2 diabetes. Trajenta Duo combines linagliptin and metformin to help control blood sugar levels in adults with this condition.

Composition of trajenta Duo

Trajenta Duo is composed of two active ingredients: linagliptin and metformin. Linagliptin works by increasing insulin release from the pancreas and decreasing glucagon levels, a hormone that raises blood sugar. Metformin reduces glucose production in the liver and improves insulin sensitivity, enhancing the body's ability to use insulin effectively.

Uses of trajenta Duo

• Management of type 2 diabetes
• Helps control high blood sugar levels
• Improves insulin sensitivity

Side effects of trajenta Duo

• Common side effects: nausea, diarrhea, stomach upset, runny nose, sore throat, cough
• Serious side effects: low blood sugar, lactic acidosis, pancreatitis

Precautions of trajenta Duo

When using trajenta Duo, it is important to monitor for signs of lactic acidosis and pancreatitis. Use with caution in individuals with kidney or liver problems. Always follow healthcare provider instructions and report any unusual symptoms immediately.

How to Take trajenta Duo

Trajenta Duo is typically taken as a tablet. Metformin is usually taken at a dose of 500 mg to 1000 mg two to three times a day with meals to reduce stomach upset. Linagliptin is prescribed at a dose of 5 mg once daily, regardless of meals. Follow your doctor's advice for the correct dosage and administration.

Conclusion of trajenta Duo

Trajenta Duo, a combination of linagliptin and metformin, belongs to the therapeutic class of antidiabetic medications. It is primarily used for managing type 2 diabetes by effectively controlling blood sugar levels. Manufactured by Boehringer Ingelheim, trajenta Duo offers a comprehensive approach to diabetes management. Always consult your healthcare provider for personalized advice and follow their instructions carefully.